Searchable abstracts of presentations at key conferences in endocrinology

ea0081mte12 | Diagnostic approach and clinical management of hypophosphatemia: Is it really an endocrine disorder?. | ECE2022

Diagnostic approach and clinical management of hypophosphatemia: Is it really an endocrine disorder?

Corbetta Sabrina

Phosphorus is involved in energy storage, metabolism, nucleic acids, cell membrane function, cell signaling; it is a fundamental constituent of skeleton and teeth. Pi homeostasis is regulated mainly by three hormones, namely parathyroid hormone (PTH), vitamin D and Fibroblast Growth Factor 23 (FGF23). Additionally, sex hormones are known to decrease circulating Pi levels, by reducing renal tubular reabsorption through direct and indirect effects on renal phosphate channels and...

ea0081ep1166 | Late Breaking | ECE2022

Does Autonomic cortisol secretion really affect metabolic parameters? preliminary results

Karslı Seda , Turgut Seda , Acarer Bugun Didem , Pamuk Naim , Piskinpasa Hamide , Cakir İlkay , Mert Meral , Ciftci Sema

Aim: Autonomic cortisol secretion (ACS) is a clinical picture without overt signs of Cushing’s Syndrome despite adrenal adenoma and ACTH-independent cortisol secretion. These patients, who currently do not have a standard treatment, are followed up, especially for known comorbidities of hypercortisolemia such as obesity, diabetes mellitus (DM), hypertension, osteoporosis, and hyperlipidemia. However, it remains unclear how long the patients will be followed and when the t...

ea0063s19.2 | Adrenal insufficiency | ECE2019

Long-term results of modified release glucocorticoids in adrenal insufficiency – are they really better?

Johannsson Gudmundur

Before the availability of glucocorticoids as drugs, the majority of patients with primary adrenal insufficiency (AI) died within 2 years of diagnosis. Today patients with AI receive life-long replacement therapy with glucocorticoids with the assumption that life expectancy is normal. Recent studies have, however, shown excess mortality in patients with both primary and secondary AI mainly due to cardiovascular diseases and infections. Patients with AI also have increased rate...

ea0021p393 | Thyroid | SFEBES2009

Radioiodine for Graves’ disease: what do patients really think?

Fletcher Rebecca , Muir Kenneth , Bevan John , Abraham Prakash

Introduction: Radioactive iodine (RAI) is a commonly used treatment modality in Graves’ hyperthyroidism. Patient choice is a major factor in advising radioiodine but there are few data on patient satisfaction following treatment.Method: QuestionnaireAn anonymised questionnaire was distributed to 100 individuals on the thyroid register with RAI treated Graves’ hyperthyroidism. The survey included questions relating to side...

ea0056p821 | Pituitary - Clinical | ECE2018

Clinical relevance of metabolic phenotype in hypopituitarism: what really matters?

Miljic Dragana , Pekic Sandra , Doknic Mirjana , stojanovic Marko , Nikolic-Djurovic Marina , Medic-Stojanoska Milica , Milosevic Verica , Sosic-Jurijevic Branka , Ajdzanovic Vladimir , Jemuovic Zvezdana , Soldatovic Ivan , Popovic Vera , Petakov Milan

Previous studies reported increased prevalence of metabolic syndrome (MS) and mortality rates from cardiovascular causes in hypopituitary patients. Fatty liver disease was added recently to this unfavorable cardio-metabolic phenotype. We studied the prevalence of MS and non-alcoholic fatty liver disease (NAFLD) in unselected cohort of 282 hypopituitary patients (146 male), mean age 49.2±15.1 years, on standard replacement therapy (76.4% received l-thyroxin, 76% hydrocorti...

ea0096p10 | Section | UKINETS2023

A prrt patient experience survey – what really matters to patients?

Coldham Mr. Chris , Butler Mrs Vicky , Brown Mrs Emily , Smith Mrs Stacey , Shah Dr. Tahir

Introduction/Background: PRRT is a high cost treatment for progressing Neuroendocrine tumours. Patients and healthcare providers invest heavily in the treatment journey that lasts a number of months.Aims: To assess the level of patient satisfaction with the PRRT service, to indicate areas for possible improvement and good practice and serve as a baseline for future assessments.Material and ...

ea0090p551 | Adrenal and Cardiovascular Endocrinology | ECE2023

Does this patient really have a pheochromocytoma? A retrospective analysis of patients undergoing adrenalectomy overdiagnosed with pheochromocytoma

Zawadzka Karolina , Małczak Piotr , Wysocki Michał , Major Piotr , Pędziwiatr Michał , Pisarska-Adamczyk Magdalena

Background: Pheochromocytoma and paraganglioma (PPGL) are rare endocrine tumours that secrete catecholamines. Methoxycatecholamines in free plasma or fractionated methoxycatecholamines in 24-hour urine collections are the recommended tests for the diagnosis of pheochromocytoma, based on which patients are referred for surgical removal of the adrenal gland. However, false-positive results from these tests remain a problem and some patients are referred for adrenalectomy due to ...

ea0037ep182 | Reproduction, endocrine disruptors and signalling | ECE2015

Is serum estradiol really increased in patients with Klinefeler syndrome? Results from a meta-analysis study

Santi Daniele , Scaltriti Sara , Rochira Vincenzo

Background and aim: KS has been classically described as characterized by hyperestrogenism and elevated serum E2 together with increased gonadotropins and low-to-normal serum testosterone (T). In literature, data on increased serum E2 are not solid. The aim of this study is to meta-analyse data from studies evaluating serum E2 in both KS and healthy subjects (HS) in order to verify if E2 is increased in KS.Meth...

ea0070aep68 | Adrenal and Cardiovascular Endocrinology | ECE2020

Does adrenal vein sampling really improve the final approach for treating prymary aldosteronism? a retrospective study.

León Mengíbar Josep , Capel Flores Ismael , Subias Andujar David , Perendreu Sans Juan , Almirall Daly Jaume , Berlanga Escalera Eugenio , Rigla Mercedes

Introduction: Primary aldosteronism (PA) causes 15–25% of cases of drug-resistant hypertension (RBP). Adrenal vein sampling (AVS) is considered the gold standard for diagnosis of aldosterone aberrant secretion origin. The distinction between unilateral and bilateral disease dictates the targeted therapeutic approach, with surgery for aldosterone producing adenomas and medical therapy for patients with bilateral hyperplasia. As AVS is an invasive, not well standardized pr...